Showing results (1111-1120 of 1,128) with videos related to
Sort By:
Pageof 113
The Lancet. Oncology|January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyMark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Pancreatic Adenocarcinoma, Version 1.2019Margaret A Tempero, Mokenge P Malafa, E Gabriela Chiorean, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.Nature Communications|October 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptorsCecily Choy, Joseph Chen, Jiangyuan Li, et al.Science Translational Medicine|March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastomaPriya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.Nature|September 7, 2022
A sustained high-temperature fusion plasma regime facilitated by fast ionsH Han, S J Park, C Sung, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in OncologyE Gabriela Chiorean, Marco Del Chiaro, Margaret A Tempero, et al.Plos Biology|December 24, 2003
Transcriptome analysis of mouse stem cells and early embryosAlexei A Sharov, Yulan Piao, Ryo Matoba, et al.Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.Pageof 113